Our Blog

Read the recent posts in our blog here or check the Publications page.

Akceso’s ‘Evidence-based Asset Valuation’ methodology
Akceso’s ‘Evidence-based Asset Valuation’ methodology

What the three-part evidence-gathering method includes and how it helps to achieve both patient- & public health benefit and long-term economic success.

Read More →
IMD High-Performance Leadership program led by Professor George Kohlrieser
How a hostage negotiator can inspire business leaders?

Read the thoughts of András Incze related to the Advanced High-Performance Leadership (HPL) program led by Professor George Kohlrieser.

Read More →
How to link the challenge of the Blue Trail with the development of a pharma pricing tool
One of the things I learnt from Akceso – always welcome challenges

One of the things that I have learnt during my time with Akceso is that, if you believe that something is good and brings value, do not wait to start doing it.

Read More →
Why the World needs Catalysts
Why the World needs Catalysts?

’Catalysts to patient access and pricing success for better public health – worldwide.’ This is our motto. Based on Renáta Vincze’s writing, we see how important catalysts can be.

Read More →
Working remotely – How does this work at Akceso Advisors? What are the benefits for our clients?
Working remotely – How does this work at Akceso Advisors? What are the benefits for our clients?

Working remotely is here to stay! The Covid pandemic gave it an enormous boost. While working remotely has a lot of benefits, it is not all rosy.

Read More →
Food donation
Applying Pharma Market Access Models to Food

What is the common between food supply, the Netflix, and pharma market access?

Read More →
Frontiers Publication about ERP
External Reference Pricing may have negative effects globally? – research article in Frontiers

This 5 years of research explores how external reference pricing (ERP, or also called as IRP – International Reference Pricing) is used to set pharmaceutical prices to improve affordability, but how its application may have negative consequences on patient access across certain countries.

Read More →
We Look Back To A Remarkable Year 2021
We Look Back To A Remarkable Year 2021

We are happy to share with you the blog post of András Incze, CEO of Akceso Advisors on what was accomplished, how we made an impact with our international team in these challenging times and lived up again to our promise.

Read More →
The Essence of 17 Years in Marathon Running
The Essence of 17 Years in Marathon Running

4 good reasons of running marathon: Read thoughts of András Incze about how marathon running became a passionate habit for him and how it reflects in Akceso.

Read More →
This is goldmine - Testimonial for a Pricing Strategy project
Satisfied Client of Our Recent Pricing Strategy Project

At the beginning of October we have delivered the result of a MarketScout service project and our client was really satisfied. Read their feedback!

Read More →
Pricing & Reimbursement Recommendation Testimonial
Great Feedback For Our Recent Pricing & Reimbursement Project

“I am really pleased with the outcome…. and seldom agree so quickly with recommendations!” – said one of our client about the recent pricing & reimbursement project have we delivered.

Read More →
No International Reference Pricing for drugs in the US
No International Reference Pricing for drugs in the US – good news for patients in the US and worldwide

The US Government just published its “Comprehensive Plan for Addressing High Drug Prices”. It lists a number of initiatives and ideas, but does NOT mention is International Reference Pricing – and this is good news for patients in the US and worldwide (and for manufacturers, too). – Read the Akceso Advisors reflection on a latest development in the US pharmaceuticals market based on Akceso Advisors’ research related to the impact of International Reference Pricing (IRP) on patient access and innovation.

Read More →
Publication Co-Authored by Dávid Deritei
New Publication Co-Authored by Dávid Deritei

Parity and time reversal elucidate both decision-making in empirical models and attractor scaling in critical Boolean networks – featured on the top journal Science Advances

Read More →
New Team Member Károly Dénes Price Modeler
Károly Dénes has joined to Akceso

Károly Dénes has joined our team in February 2021. Meet our newest Akcesoian!

Read More →
10 Years in More Numbers

Akceso Advisors generated up to an additional 12% sales revenue for clients!

Read More →
10 Years in Numbers

To commemorate the 10th anniversary of Akceso Advisors we have collected a few facts and figures, demonstrating the successes and milestones.

Read More →
Akceso Advisors:  Catalysts to patient access and pricing success. For better public health – worldwide.

The best tools for your challenges.

Get in touch with us and schedule a demo.

[contact-form-7 404 "Not Found"]

Join our mailing list!

The PRiMA Headlines Newsletter provides a monthly overview of developments in Pricing, Reimbursement and Market Access developments across the globe. Since its launch in June 2015 we have covered more than 5,000 stories from over 100 countries.

Scroll to Top